Healthcare - Drug Manufacturers - General - NYSE - US
$ 164.99
-2.74 %
$ 292 B
Market Cap
57.69
P/E
INCOME STATEMENT
54.3 B
REVENUE
12.8 B
OPERATING INCOME
4.88 B
NET INCOME
EFFICIENCY
Earnings Waterfall
AbbVie Inc.
| Revenue | 54.3 B |
| Cost Of Revenue | 8.78 B |
| Gross Profit | 45.5 B |
| Operating Expenses | 24.8 B |
| Operating Income | 12.8 B |
| Other Expenses | 7.87 B |
| Net Income | 4.88 B |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||
| Revenue | 54 318.0 | 58 054.0 | 56 197.0 | 45 804.0 | 33 266.0 | 32 753.0 | 28 216.0 | 25 638.0 | 22 859.0 | 19 960.0 | 18 790.0 | 18 380.0 | 17 444.0 | 15 638.0 | 14 214.2 |
| GROSS PROFIT | |||||||||||||||
| Cost Of Revenue | 8 780.0 | 17 414.0 | 17 446.0 | 15 387.0 | 7 439.0 | 7 718.0 | 7 040.0 | 5 833.0 | 4 500.0 | 4 426.0 | 4 581.0 | 4 508.0 | 4 639.4 | 4 293.0 | 4 056.4 |
| Gross Profit | 45 538.0 | 40 640.0 | 38 751.0 | 30 417.0 | 25 827.0 | 25 035.0 | 21 176.0 | 19 805.0 | 18 359.0 | 15 534.0 | 14 209.0 | 13 872.0 | 12 804.6 | 11 345.0 | 10 157.8 |
| OPERATING INCOME | |||||||||||||||
| Operating Expenses | 24 835.0 | 21 826.0 | 19 865.0 | 17 856.0 | 12 459.0 | 18 228.0 | 11 257.0 | 10 221.0 | 10 672.0 | 11 771.0 | 8 207.0 | 7 767.0 | 8 511.3 | 6 315.0 | 5 056.0 |
| Selling, General and Administrative Expenses | 12 872.0 | 15 260.0 | 12 349.0 | 11 299.0 | 6 942.0 | 7 399.0 | 6 275.0 | 5 855.0 | 6 387.0 | 7 724.0 | 5 352.0 | 4 989.0 | 5 893.8 | 3 820.0 | 3 348.6 |
| Research and Development Expenses | 8 453.0 | 6 510.0 | 7 084.0 | 6 557.0 | 6 407.0 | 10 329.0 | 4 982.0 | 4 366.0 | 4 285.0 | 3 297.0 | 2 855.0 | 2 778.0 | 2 617.5 | 2 495.0 | 1 707.4 |
| Operating Income | 12 757.0 | 18 117.0 | 17 924.0 | 11 363.0 | 12 983.0 | 6 383.0 | 9 545.0 | 9 340.0 | 7 537.0 | 3 411.0 | 5 664.0 | 6 622.0 | 3 620.7 | 4 717.0 | 4 931.8 |
| PRE-TAX INCOME | |||||||||||||||
| Interest Income Expense | 2 224.0 | 2 230.0 | 2 423.0 | 2 454.0 | 1 784.0 | 1 348.0 | 1 150.0 | 1 047.0 | 719.0 | 429.0 | 299.0 | 104.0 | 0 | 0 | 0 |
| Total Other Income | (6 507.0) | (4 640.0) | (4 935.0) | (7 965.0) | (4 557.0) | (1 186.0) | (1 818.0) | (1 456.0) | (892.0) | (1 042.0) | (332.0) | (92.0) | 48.5 | (320.0) | 806.5 |
| Pre-Tax Income | 6 250.0 | 13 477.0 | 12 989.0 | 3 398.0 | 8 426.0 | 5 197.0 | 7 727.0 | 7 884.0 | 6 645.0 | 2 369.0 | 5 332.0 | 5 725.0 | 3 668.5 | 4 836.0 | 5 950.3 |
| NET INCOME | |||||||||||||||
| Tax Provision | 1 377.0 | 1 632.0 | 1 440.0 | 1 224.0 | 544.0 | 490.0 | 2 418.0 | 1 931.0 | 1 501.0 | 595.0 | 1 204.0 | 450.0 | 235.4 | 658.0 | 1 313.8 |
| Net Income | 4 863.0 | 11 836.0 | 11 542.0 | 4 616.0 | 7 882.0 | 5 687.0 | 5 309.0 | 5 953.0 | 5 144.0 | 1 774.0 | 4 128.0 | 5 275.0 | 3 433.1 | 4 178.0 | 4 636.5 |
| EPS | 2.73 | 6.65 | 6.48 | 2.73 | 5.3 | 3.69 | 3.31 | 3.65 | 3.15 | 1.11 | 2.58 | 3.35 | 2.12 | 2.59 | 2.87 |